NCT03563976 Multiparametric Image Analysis and Correlation With Outcomes in Lung Cancer Screening and Early Stage Lung Cancer
| NCT ID | NCT03563976 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Texas Southwestern Medical Center |
| Condition | Lung Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 2,000 participants |
| Start Date | 2015-02-18 |
| Primary Completion | 2029-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 2,000 participants in total. It began in 2015-02-18 with a primary completion date of 2029-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Determine whether CT-based multiparametric analytical models may improve prediction of biopsy and treatment outcome in patients undergoing screening CT scan and/or treatment for early stage lung cancer
Eligibility Criteria
Inclusion Criteria: Patients that have been diagnosed with lung cancer, and are treated at Department of Radiation Oncology, UTSW or Parkland Memorial Hospital. Exclusion Criteria: There will be no absolute exclusion criteria as long as the inclusion criteria have been met.
Contact & Investigator
Jing Wang, MD
PRINCIPAL INVESTIGATOR
UTSW Radiation Oncology
Frequently Asked Questions
Who can join the NCT03563976 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 99 Years, studying Lung Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03563976 currently recruiting?
Yes, NCT03563976 is actively recruiting participants. Contact the research team at Sarah.hardee@UTSouthwestern.edu for enrollment information.
Where is the NCT03563976 trial being conducted?
This trial is being conducted at Dallas, United States.
Who is sponsoring the NCT03563976 clinical trial?
NCT03563976 is sponsored by University of Texas Southwestern Medical Center. The principal investigator is Jing Wang, MD at UTSW Radiation Oncology. The trial plans to enroll 2,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.